A review by Kalipso Chalkidou and colleagues published in the Milbank Quarterly compares the characteristics of health technology assessment entities in the UK, France, Germany, and Australia. The full report can be accessed online here; it summarises common themes which may inform current efforts to establish comparative effectiveness research in the US. Firstly, the authors set out the procedures which characterise functioning health technology assessment (such as independence from government, transparency, and scientific rigour). Secondly, they emphasise the evolving role of these organisations, for example in taking on new roles such as influencing national health research agenda. Finally, the review sets out the importance of “selling” the role of health technology assessment to stakeholders, and of setting up appropriate governance and oversight, particularly in relation to conflict of interest policy.
- Forced to Flee: Humanitarian Disasters Leave Women at Higher Risk
- Looking for $2 Trillion
- Is Viral Load Testing for HIV a Realistic Strategy in Developing Countries?
- Vaccine Hesitancy: A Call for Papers from PLOS Currents: Outbreaks
- Drugs for the Poor, Drugs for the Rich: Why the Current R&D Model Doesn’t Deliver
- Is the American Health Profession Ignoring a Human Rights Issue Hiding in Plain Sight?
TopicsAfrica antimicrobial drugs antiretroviral treatment cardiovascular health child health china clinical trials developing world diarrhea environment Ghostwriting global burden of disease global health guidelines health costs health information health policy health systems HIV HIV/AIDS influenza LMICs malaria maternal and perinatal health maternal health medical literature medical students Mental Health mortality MSF neglected tropical diseases open access pharmaceutical industry Policy public health reporting research ethics sanitation sub-saharan Africa systematic reviews tobacco tuberculosis vaccine water WHO